GO:0009113 purine nucleobase biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009113 purine nucleobase biosynthetic process describes the chemical reactions and pathways that build purine nucleobases such as adenine and guanine, the nitrogen-containing ring compounds found in DNA and RNA.
• The pathway is a core metabolic hub that supplies the nucleobase building blocks for nucleotides, nucleic acids, and cofactors, and it is a validated drug target in tuberculosis and malaria [1,8].
• Nucleobase biosynthesis and transport are tightly coupled because cells must both make and salvage purines; dedicated nucleobase transporters move these compounds across membranes [2,6].
• Purine nucleobase metabolism intersects with immunity, DNA modification, and microbiome signaling, including CBASS immunity and butyrate generation by engineered E. coli [3,7].
• Enzymes such as nucleoside phosphorylases can generate non-canonical nucleobases like N7-xanthosine, expanding the known chemistry of this pathway.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect which genes in this pathway are causal for disease phenotypes.
Description
Purine nucleobase biosynthetic process (GO:0009113) is the set of chemical reactions and pathways that result in the formation of purine nucleobases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine. This process sits at the intersection of central metabolism, nucleic acid synthesis, and cellular signaling, and it is conserved from bacteria to humans. Researchers study it because purine nucleobases are not only building blocks of genetic material but also precursors of cofactors and signaling molecules, and because the pathway is essential in pathogens that cause tuberculosis and malaria [1,8]. The pathway is also a model for understanding how cells balance de novo synthesis with salvage and transport. Nucleobase transporters are required to move purines and pyrimidines across membranes, and their specificity shapes how cells and organisms acquire these nutrients [2,6]. In microbial communities, purine nucleobase release can influence host physiology, as shown by engineered E. coli that promote butyrate generation and colonic wound healing. From a disease perspective, purine nucleobase biosynthesis is a validated target in Mycobacterium tuberculosis, where de novo purine biosynthesis is required for pathogenesis and can be inhibited therapeutically. In malaria parasites, purine nucleobase transport is essential for salvage and represents a potential drug target. These examples illustrate why GO:0009113 is a high-value term for both basic and translational research.
purine nucleobase biosynthetic process At A Glance
| GO ID | GO:0009113 |
|---|---|
| GO term | purine nucleobase biosynthetic process |
| Ontology | biological_process |
| Synonym | purine base anabolism; purine base biosynthesis; purine base biosynthetic process; purine base formation; purine base synthesis |
| Major function | Formation of purine nucleobases such as adenine and guanine, the nitrogen-containing ring compounds found in DNA and RNA |
| Pathway class | Small molecule metabolism; nucleobase biosynthesis |
| Key substrates | Purine ring precursors including amino acids, formate, and glycine-derived intermediates |
| Key products | Purine nucleobases (adenine, guanine, and related bases) |
| Related processes | Purine nucleotide biosynthesis, purine salvage, nucleobase transport |
| Disease relevance | Tuberculosis, malaria, cancer metabolism, and immune signaling |
What Is GO:0009113?
GO:0009113 purine nucleobase biosynthetic process is defined as the chemical reactions and pathways resulting in the formation of purine nucleobases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine. In practical terms, it covers the enzymatic steps that assemble the purine ring and produce free nucleobases, as distinct from nucleotide or nucleoside biosynthesis. Synonyms include purine base anabolism, purine base biosynthesis, purine base biosynthetic process, purine base formation, and purine base synthesis.
Why Is purine nucleobase biosynthetic process Important in Cell Biology?
GO:0009113 is important because purine nucleobases are indispensable for DNA and RNA synthesis, energy metabolism, and signaling, and because the pathway is a proven vulnerability in pathogens and a key node in host-microbe interactions. Targeting de novo purine biosynthesis is a validated strategy for tuberculosis treatment, and purine nucleobase transport is essential in malaria parasites. Beyond infection, nucleobase metabolism intersects with immunity and DNA modification, as shown by deazaguanylation in type IV CBASS immunity and nucleoside-driven specificity of DNA methyltransferases. Understanding this pathway therefore informs drug discovery, microbiome engineering, and fundamental cell biology.
• Provides the purine nucleobases adenine and guanine that are essential for DNA and RNA.
• Supplies precursors for nucleotides, cofactors, and signaling molecules.
• Is a validated drug target in Mycobacterium tuberculosis.
• Is essential for purine salvage and transport in malaria parasites.
• Connects to immune defense through nucleobase-protein conjugation in CBASS immunity.
• Influences host-microbe interactions and colonic wound healing via engineered E. coli.
• Intersects with epigenetic regulation through nucleoside-driven DNA methyltransferase specificity.
• Expands known nucleobase chemistry through enzymes such as nucleoside phosphorylases.
• Requires dedicated nucleobase transporters for uptake and distribution [2,6].
• Offers a rich set of CRISPR targets for functional genomics and drug discovery.
What Happens During purine nucleobase biosynthetic process?
Overview of purine nucleobase biosynthesis
In simple terms: Cells build purine bases from small molecules in a step-by-step assembly line.
The purine nucleobase biosynthetic process (GO:0009113) encompasses the chemical reactions and pathways that form purine nucleobases, including adenine and guanine. This process is distinct from salvage pathways that recycle preformed bases, and it is required when demand for purines exceeds salvage capacity. In pathogens such as Mycobacterium tuberculosis, de novo purine biosynthesis is essential and can be targeted for treatment. The pathway also interfaces with transport systems that move nucleobases across membranes [2,6].
Ring assembly and key intermediates
In simple terms: The purine ring is built atom by atom from simple precursors.
Purine nucleobase biosynthesis proceeds through a series of enzymatic steps that assemble the purine ring from precursors such as amino acids and formate. While the exact intermediates vary across organisms, the overall logic is conserved: build the ring, then release the nucleobase. Enzymes such as nucleoside phosphorylases can also act on nucleosides to generate non-canonical bases like N7-xanthosine, illustrating the chemical versatility of this pathway. These reactions are central to supplying the nucleobase pool for nucleic acid synthesis.
Nucleobase transport and salvage coupling
In simple terms: Cells must move purine bases in and out, and they can recycle them.
Nucleobase transporters are integral membrane proteins that mediate the uptake and efflux of purines and pyrimidines, and their specificity shapes how cells acquire these nutrients [2,6]. In the intraerythrocytic malaria parasite, purine nucleobase transport is essential for salvage because the parasite cannot synthesize purines de novo. Thus, GO:0009113 is functionally coupled to transport and salvage, and disrupting either arm can perturb purine homeostasis.
Physiological and microbial roles
In simple terms: Purine bases affect how microbes interact with their hosts.
Beyond nucleic acid synthesis, purine nucleobase metabolism influences host physiology. E. coli genetically modified for purine nucleobase release promotes butyrate generation and colonic wound healing during DSS insult. In immunity, deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity. These findings show that GO:0009113-related chemistry has broad biological impact beyond classical nucleotide metabolism.
Key Genes Involved in GO:0009113 purine nucleobase biosynthetic process
The following genes and proteins are representative of the enzymes, transporters, and regulatory factors that participate in or modulate purine nucleobase biosynthetic process (GO:0009113) and its associated salvage and transport systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| purF | Glutamine phosphoribosylpyrophosphate amidotransferase, first committed step of de novo purine biosynthesis | Target for tuberculosis drug discovery |
| purD | Phosphoribosylamine-glycine ligase in purine biosynthesis | Essential for de novo purine synthesis in pathogens |
| purN | Phosphoribosylglycinamide formyltransferase | Potential target in purine pathway inhibition |
| purL | Phosphoribosylformylglycinamidine synthase | Required for purine ring assembly |
| purM | Phosphoribosylaminoimidazole synthetase | Involved in purine intermediate formation |
| purE | Phosphoribosylaminoimidazole carboxylase | Catalyzes a step in purine biosynthesis |
| purC | Phosphoribosylaminoimidazolesuccinocarboxamide synthase | Purine pathway enzyme |
| purB | Adenylosuccinate lyase | Links purine biosynthesis to nucleotide pools |
| purH | AICAR transformylase/IMP cyclohydrolase | Bifunctional enzyme in purine biosynthesis |
| purA | Adenylosuccinate synthetase | Converts IMP toward adenine nucleotides |
| purB (E. coli) | Adenylosuccinate lyase in E. coli purine release | Engineered for butyrate generation and wound healing |
| nucleoside phosphorylase | Generates N7-xanthosine and related nucleobases | Expands nucleobase chemistry |
| nucleobase transporter (Plasmodium) | Purine nucleobase transport in malaria parasite | Drug target for malaria |
| nucleobase transporter (mammalian) | Mediates nucleobase uptake in mammals | Determines drug pharmacokinetics |
| nucleobase transporter (general) | Membrane transport of purines and pyrimidines | Central to salvage and homeostasis |
| DNA methyltransferase | Nucleoside-driven specificity in DNA modification | Links nucleobase metabolism to epigenetics |
| CBASS effector | Deazaguanylation for type IV CBASS immunity | Connects nucleobase conjugation to immunity |
How Is purine nucleobase biosynthetic process Regulated?
Purine nucleobase biosynthetic process is regulated at multiple levels, including transcriptional control of biosynthetic genes, feedback inhibition by purine nucleotides, and coordination with salvage and transport pathways. In Mycobacterium tuberculosis, de novo purine biosynthesis is required for pathogenesis and its inhibition is a therapeutic strategy. Nucleobase transporters are also regulated to match cellular demand, as reviewed for mammalian systems and for protozoan parasites [2,8]. In microbial communities, purine nucleobase release can be engineered to influence host metabolism, as shown by E. coli modified for purine release that promotes butyrate generation and colonic wound healing.
purine nucleobase biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| purF | Tuberculosis pathogenesis | Mycobacterium tuberculosis knockout and inhibitor testing |
| purD | Tuberculosis drug target | Conditional knockout in M. tuberculosis |
| Nucleobase transporter | Malaria parasite survival | Plasmodium transporter knockout and transport assays |
| DNA methyltransferase | Epigenetic regulation in cancer | Nucleoside analog treatment and methylation profiling |
| CBASS effector | Type IV CBASS immunity | Deazaguanylation conjugation assays |
Tuberculosis
Mycobacterium tuberculosis depends on de novo purine biosynthesis for growth and pathogenesis, and targeting this pathway is a validated treatment strategy. This makes GO:0009113 a high-priority term for antibacterial drug discovery.
Malaria
The intraerythrocytic malaria parasite cannot synthesize purines de novo and relies on purine nucleobase transport for salvage, making transporters attractive drug targets. This links GO:0009113-related transport to antimalarial therapy.
Cancer metabolism and epigenetics
Nucleoside-driven specificity of DNA methyltransferases connects nucleobase metabolism to epigenetic regulation, which is relevant to cancer biology and drug development. Purine availability can influence DNA modification patterns and gene expression.
Immune signaling and microbiome
Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity, showing that purine nucleobase chemistry participates in immune defense. Engineered E. coli that release purine nucleobases promote butyrate generation and colonic wound healing, linking this pathway to host-microbe interactions.
From purine nucleobase biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a purine biosynthetic gene essential for pathogen growth? | CRISPR knockout in Mycobacterium tuberculosis |
| Does a nucleobase transporter mediate drug uptake? | Knockout and point-mutation in Plasmodium |
| Can purine release modulate host metabolism? | Engineered E. coli overexpression of purine release genes |
| How does nucleobase chemistry affect DNA methylation? | Point-mutation of DNA methyltransferase and nucleoside analogs |
| What is the role of nucleobase conjugation in immunity? | Knock-in of tagged CBASS effectors |
| Can nucleoside phosphorylases generate novel bases? | Overexpression and enzymatic assays |
How to Study the purine nucleobase biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for purine biosynthesis | Target discovery in tuberculosis |
| Metabolomics (LC-MS) | Purine nucleobase abundance | Pathway flux and drug response |
| Transport assays | Nucleobase uptake and efflux | Transporter characterization [2,6,8] |
| RNA-seq | Transcriptional response of purine genes | Regulatory studies |
| Proteomics | Enzyme expression and modifications | Pathway protein dynamics |
| Enzymatic assays | Nucleoside phosphorylase activity | Novel nucleobase synthesis |
| DNA methylation profiling | Epigenetic changes from nucleoside analogs | Cancer and epigenetics |
| Microbiome engineering | Purine release and butyrate production | Host-microbe interaction |
Genomic and CRISPR screens
CRISPR knockout and interference screens can identify genes required for purine nucleobase biosynthetic process, as demonstrated by targeting de novo purine biosynthesis in Mycobacterium tuberculosis. These screens link genotype to fitness and drug sensitivity.
Metabolomics and flux analysis
Mass spectrometry-based metabolomics measures purine nucleobase levels and flux through the pathway. This approach is essential to confirm that genetic perturbations alter adenine and guanine pools, and it complements studies of nucleoside phosphorylase products such as N7-xanthosine.
Transport assays
Radiolabeled or fluorescent nucleobase uptake assays measure transporter activity in mammalian cells and parasites [2,6,8]. These assays are critical for linking GO:0009113 to membrane transport and drug uptake.
Immunity and conjugation assays
Biochemical and genetic assays can detect nucleobase-protein conjugation, such as deazaguanylation in type IV CBASS immunity. These methods reveal non-canonical roles of purine nucleobases beyond nucleic acid synthesis.
How CRISPR Can Be Used to Study GO:0009113 purine nucleobase biosynthetic process
Knockout
CRISPR knockout of purine biosynthetic genes such as purF and purD in Mycobacterium tuberculosis can test essentiality and validate drug targets. Knockout of nucleobase transporters in Plasmodium can reveal their role in salvage and survival.
Point Mutation
Point mutations can dissect catalytic residues and substrate specificity in purine pathway enzymes and transporters. For example, point mutations in nucleobase transporters can identify residues required for substrate recognition [2,6].
Knock-in
Knock-in of tagged or reporter alleles allows tracking of purine biosynthetic enzymes and immune effectors such as CBASS proteins involved in deazaguanylation. This approach enables precise localization and interaction studies.
Overexpression
Overexpression of purine release genes in E. coli promotes butyrate generation and colonic wound healing, demonstrating the physiological impact of increasing purine nucleobase availability. Overexpression of nucleoside phosphorylases can also drive production of non-canonical bases like N7-xanthosine.
How EDITGENE Supports purine nucleobase biosynthetic process Research
Researchers studying purine nucleobase biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway activity, drug response, or disease phenotypes. Rigorous causal inference requires well-controlled genetic models that can isolate the contribution of individual enzymes, transporters, and regulatory factors. EDITGENE provides end-to-end CRISPR services to generate such models efficiently and reproducibly.
Contact EDITGENE today to design your custom CRISPR model for purine nucleobase biosynthetic process research.
Frequently Asked Questions About purine nucleobase biosynthetic process
What is GO:0009113 purine nucleobase biosynthetic process?
GO:0009113 is the biological process comprising the chemical reactions and pathways that form purine nucleobases such as adenine and guanine, the nitrogen-containing ring compounds found in DNA and RNA.
What genes are involved in purine nucleobase biosynthetic process?
Genes include purF, purD, purN, purL, purM, purE, purC, purB, purH, and purA in bacteria, as well as nucleoside phosphorylases and nucleobase transporters in other organisms [1,2,4,6,8].
Why is purine nucleobase biosynthesis important for tuberculosis?
Mycobacterium tuberculosis requires de novo purine biosynthesis for growth and pathogenesis, and targeting this pathway is a validated treatment strategy.
How is purine nucleobase biosynthesis linked to malaria?
The malaria parasite cannot synthesize purines de novo and depends on purine nucleobase transport for salvage, making transporters potential drug targets.
What is the role of nucleobase transporters in this pathway?
Nucleobase transporters move purines and pyrimidines across membranes, coupling biosynthesis to salvage and distribution in cells and organisms [2,6].
Can purine nucleobases affect the immune system?
Yes, deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity, linking purine chemistry to immune defense.
How do nucleoside phosphorylases relate to purine nucleobases?
Nucleoside phosphorylases can generate non-canonical nucleobases such as N7-xanthosine, expanding the known chemistry of purine metabolism.
What research methods are used to study purine nucleobase biosynthesis?
Common methods include CRISPR knockout screens, metabolomics, transport assays, RNA-seq, proteomics, and enzymatic assays [1,2,4,6,8].
Can purine nucleobase release affect the gut microbiome?
Yes, E. coli engineered for purine nucleobase release promotes butyrate generation and colonic wound healing during DSS insult.
How does purine metabolism connect to epigenetics?
Nucleoside-driven specificity of DNA methyltransferases links nucleobase metabolism to DNA modification and epigenetic regulation.
Conclusion
GO:0009113 purine nucleobase biosynthetic process is a fundamental metabolic pathway that supplies the purine bases adenine and guanine for DNA, RNA, and cofactor synthesis. Its importance extends from antibacterial and antimalarial drug discovery to immunity, epigenetics, and microbiome engineering [1,3,5,7,8]. Understanding the enzymes, transporters, and regulatory mechanisms of this pathway requires robust genetic models and quantitative methods. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with metabolomics and screening, provide a powerful toolkit to dissect purine nucleobase biosynthesis. EDITGENE offers comprehensive services to accelerate this research and translate pathway insights into therapeutic strategies.
References
- 1. Lamprecht DA et al.. 2025. Targeting de novo purine biosynthesis for tuberculosis treatment.. Nature 644(8075):214-220 PMID: 40533558
- 2. de Koning H et al.. 2000. Nucleobase transporters (review).. Mol Membr Biol 17(2):75-94 PMID: 10989458
- 3. Wassarman DR et al.. 2025. Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity.. Science 389(6767):1347-1352 PMID: 40997174
- 4. Westarp S et al.. 2024. Nucleoside Phosphorylases make N7-xanthosine.. Nat Commun 15(1):3625 PMID: 38684649
- 5. Gade M et al.. 2023. Nucleoside-Driven Specificity of DNA Methyltransferase.. Chembiochem 24(22):e202300094 PMID: 37548117
- 6. Inoue K. 2017. Molecular Basis of Nucleobase Transport Systems in Mammals.. Biol Pharm Bull 40(8):1130-1138 PMID: 28768993
- 7. Lee JS et al.. 2025. E. coli genetically modified for purine nucleobase release promotes butyrate generation and colonic wound healing during DSS insult.. Gut Microbes 17(1):2490211 PMID: 40247632
- 8. Downie MJ et al.. 2008. Purine nucleobase transport in the intraerythrocytic malaria parasite.. Int J Parasitol 38(2):203-9 PMID: 17765902
